NOELLE; Randolph J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for NOELLE; Randolph J..The latest application filed is for "anti-human vista antibodies and use thereof".

Company Profile

11.49.76

NOELLE; Randolph J. - Plainfield NH
Noelle; Randolph J. - Plainfiled NH
Noelle; Randolph J. - Cornish NH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-human Vista Antibodies And Use Thereof App 20220259310 - MOLLOY; Michael ; et al.	2022-08-18
Vista Modulators For Diagnosis And Treatment Of Cancer App 20220048998 - Noelle; Randolph J.	2022-02-17
Use Of Vista Agonists And Antagonists To Suppress Or Enhance Humoral Immunity App 20220040298 - GREEN; Kathy A. ; et al.	2022-02-10
Vista Antagonist And Methods Of Use App 20210361736 - NOELLE; Randolph J. ; et al.	2021-11-25
Vista modulators for diagnosis and treatment of cancer Grant 11,180,557 - Noelle November 23, 2	2021-11-23
Anti-human Vista Antibodies And Use Thereof App 20210317207 - NOELLE; Randolph J. ; et al.	2021-10-14
Use of vista agonists and antagonists to suppress or enhance humoral immunity Grant 11,123,426 - Green , et al. September 21, 2	2021-09-21
VISTA Antagonist and Methods of Use App 20210253708 - Noelle; Randolph J. ; et al.	2021-08-19
Novel VISTA-Ig constructs and the use of VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders App 20210147521 - Noelle; Randolph J. ; et al.	2021-05-20
Vista Regulatory T Cell Mediator Protein, Vista Binding Agents And Use Thereof App 20210139578 - NOELLE; Randolph J. ; et al.	2021-05-13
ANTI-CD154 ANTIBODIES HAVING IMPAIRED FcR BINDING AND/OR COMPLEMENT BINDING PROPERTIES AND USE IN THERAPY App 20210130482 - Noelle; Randolph J.	2021-05-06
VISTA antagonist and methods of use Grant 10,933,115 - Noelle , et al. March 2, 2	2021-03-02
Vista-ig For Treatment Of Autoimmune, Allergic And Inflammatory Disorders App 20210032317 - Noelle; Randolph J. ; et al.	2021-02-04
Anti-human Vista Antibodies And Use Thereof App 20210017281 - MOLLOY; Michael ; et al.	2021-01-21
Anti-CD154 antibodies having impaired FcR binding and/or complement binding properties and related therapies Grant 10,858,439 - Noelle December 8, 2	2020-12-08
Methods of immune therapy with anti-CD154 antibodies having Fc modifications Grant 10,822,423 - Noelle November 3, 2	2020-11-03
VISTA regulatory T cell mediator protein, VISTA binding agents and use thereof Grant 10,781,254 - Noelle , et al. Sept	2020-09-22
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders Grant 10,745,467 - Noelle , et al. A	2020-08-18
Vista Antagonist And Methods Of Use App 20200093902 - NOELLE; Randolph J. ; et al.	2020-03-26
ANTI-CD154 ANTIBODIES HAVING IMPAIRED FcR BINDING AND/OR COMPLEMENT BINDING PROPERTIES AND RELATED THERAPIES App 20190309081 - Noelle; Randolph J.	2019-10-10
Regulatory T Cell Mediator Proteins And Uses Thereof App 20190170729 - NOELLE; Randolph J. ; et al.	2019-06-06
Anti-CD154 antibodies having impaired FcR binding and/or complement binding properties Grant 10,259,879 - Noelle	2019-04-16
Immunostimulatory Combinations App 20190083592 - NOELLE; Randolph J. ; et al.	2019-03-21
Regulatory T Cell Mediator Proteins And Uses Therof App 20190048083 - Noelle; Randolph J. ; et al.	2019-02-14
Immunostimulatory combinations Grant 10,105,426 - Noelle , et al. October 23, 2	2018-10-23
VISTA Agonist and Methods of Use App 20180237525 - Noelle; Randolph J. ; et al.	2018-08-23
Vista Modulators For Diagnosis And Treatment Of Cancer App 20180215826 - Noelle; Randolph J.	2018-08-02
Regulatory T cell mediator proteins and uses thereof Grant 10,035,857 - Noelle , et al. July 31, 2	2018-07-31
Novel VISTA-Ig constructs and the use of VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders App 20180051070 - Noelle; Randolph J. ; et al.	2018-02-22
Vista modulators for diagnosis and treatment of cancer Grant 9,890,215 - Noelle February 13, 2	2018-02-13
ANTI-CD154 ANTIBODIES HAVING IMPAIRED FcR BINDING AND/OR COMPLEMENT BINDING PROPERTIES AND USE IN THERAPY App 20180009896 - Noelle; Randolph J.	2018-01-11
Vista Regulatory T Cell Mediator Protein, Vista Binding Agents And Use Thereof App 20170334990 - NOELLE; Randolph J. ; et al.	2017-11-23
Anti-human Vista Antibodies And Use Thereof App 20170306024 - NOELLE; Randolph J. ; et al.	2017-10-26
Anti-human Vista Antibodies And Use Thereof App 20170306020 - NOELLE; Randolph J. ; et al.	2017-10-26
Methods of immune therapy with anti-CD154 antibodies having impaired FcR binding and/or complement binding properties Grant 9,758,587 - Noelle September 12, 2	2017-09-12
Use Of Vista Agonists And Antagonists To Suppress Or Enhance Humoral Immunity App 20170119877 - GREEN; Kathy A. ; et al.	2017-05-04
Vista regulatory T cell mediator protein, vista binding agents and use thereof Grant 9,631,018 - Noelle , et al. April 25, 2	2017-04-25
ANTI-CD154 ANTIBODIES HAVING IMPAIRED FcR BINDING AND/OR COMPLEMENT BINDING PROPERTIES AND RELATED THERAPIES App 20160333102 - Noelle; Randolph J.	2016-11-17
Vista Antagonist And Methods Of Use App 20160331803 - NOELLE; Randolph J. ; et al.	2016-11-17
Combination Therapy With Rar Alpha Agonists For Enhancing Th1 Response App 20160317654 - Noelle; Randolph J. ; et al.	2016-11-03
VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders App 20160318999 - Noelle; Randolph J. ; et al.	2016-11-03
Regulatory T Cell Mediator Proteins and Uses Thereof App 20160168248 - NOELLE; Randolph J. ; et al.	2016-06-16
Immunostimulatory Combinations App 20160129095 - NOELLE; Randolph J. ; et al.	2016-05-12
Methods of therapy with anti-CD154 antibodies having impaired FcR binding and/or complement binding properties Grant 9,321,833 - Noelle April 26, 2	2016-04-26
VISTA Antagonist and Methods of Use App 20160083472 - Noelle; Randolph J. ; et al.	2016-03-24
ANTI-CD154 ANTIBODIES HAVING IMPAIRED FcR BINDING AND/OR COMPLEMENT BINDING PROPERTIES AND USE IN THERAPY App 20160060348 - Noelle; Randolph J.	2016-03-03
Regulatory T cell mediator proteins and uses thereof Grant 9,217,035 - Noelle , et al. December 22, 2	2015-12-22
Immunotherapy comprising TLR9 ligand and CD40 ligand Grant 9,161,976 - Noelle , et al. October 20, 2	2015-10-20
VISTA Antagonist and Methods of Use App 20150231215 - NOELLE; Randolph J. ; et al.	2015-08-20
Methods of immune therapy with anti-CD154 antibodies having impaired FcR binding and/or complement binding properties Grant 9,028,826 - Noelle May 12, 2	2015-05-12
Vista Modulators For Diagnosis And Treatment Of Cancer App 20140341920 - NOELLE; Randolph J.	2014-11-20
Anti-CD154 antibodies having impaired FcR binding and/or complement binding properties Grant 8,852,597 - Noelle October 7, 2	2014-10-07
Novel VISTA-Ig constructs and the use of VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders App 20140220012 - Noelle; Randolph J. ; et al.	2014-08-07
Method for modulating inflammatory responses Grant 8,679,501 - Noelle , et al. March 25, 2	2014-03-25
VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders App 20140056892 - Noelle; Randolph J. ; et al.	2014-02-27
Regulatory T Cell Mediator Proteins And Uses Thereof App 20140037634 - Noelle; Randolph J. ; et al.	2014-02-06
Regulatory T Cell Mediator Proteins And Uses Thereof App 20140004537 - Noelle; Randolph J. ; et al.	2014-01-02
Use Of Tlr Agonists And/or Type 1 Interferons To Alleviate Toxicity Of Tnf-r Agonist Therapeutic Regimens App 20130302278 - Noelle; Randolph J. ; et al.	2013-11-14
ANTI-CD154 ANTIBODIES HAVING IMPAIRED FcR BINDING AND/OR COMPLEMENT BINDING PROPERTIES AND USE IN THERAPY App 20130295085 - Noelle; Randolph J.	2013-11-07
Compositions And Methods For Producing Adaptive Regulatory T Cells App 20130288362 - Noelle; Randolph J.	2013-10-31
Regulatory T cell mediator proteins and uses thereof Grant 8,501,915 - Noelle , et al. August 6, 2	2013-08-06
Vista Regulatory T Cell Mediator Protein, Vista Binding Agents And Use Thereof App 20130177557 - Noelle; Randolph J. ; et al.	2013-07-11
Regulatory T cell mediator proteins and uses thereof Grant 8,465,740 - Noelle , et al. June 18, 2	2013-06-18
ANTI-CD154 ANTIBODIES HAVING IMPAIRED FcR BINDING AND/OR COMPLEMENT BINDING PROPERTIES AND RELATED THERAPIES App 20130136734 - Noelle; Randolph J.	2013-05-30
Immunostimulatory Combinations App 20130115228 - Noelle; Randolph J. ; et al.	2013-05-09
ANTI-CD154 ANTIBODIES HAVING IMPAIRED FcR BINDING AND/OR COMPLEMENT BINDING PROPERTIES AND THE USE THEREOF IN IMMUNE THERAPIES App 20130108621 - Noelle; Randolph J.	2013-05-02
Compositions and methods for producing adaptive regulatory T cells Grant 8,415,154 - Noelle April 9, 2	2013-04-09
Ex vivo uses of immunostimulatory combinations Grant 8,329,197 - Noelle , et al. December 11, 2	2012-12-11
Regulatory T Cell Mediator Proteins And Uses Thereof App 20120301484 - Noelle; Randolph J. ; et al.	2012-11-29
Use of PD-L3 proteins and PD-L3 specific antibodies or antibody fragments to regulate CD4+ and CD8+ T cell immunity Grant 8,236,304 - Noelle , et al. August 7, 2	2012-08-07
Regulatory T Cell Mediator Proteins And Uses Thereof App 20120195894 - Noelle; Randolph J. ; et al.	2012-08-02
Regulatory T cell mediator proteins and uses thereof Grant 8,231,872 - Noelle , et al. July 31, 2	2012-07-31
Immunostimulatory Combinations App 20110280903 - Noelle; Randolph J. ; et al.	2011-11-17
TLR9 agonist and CD40 agonist immunostimulatory combinations Grant 7,993,659 - Noelle , et al. August 9, 2	2011-08-09
Regulatory T Cell Mediator Proteins And Uses Thereof App 20110027278 - Noelle; Randolph J. ; et al.	2011-02-03
Immunostimulatory Combinations App 20110002946 - Noelle; Randolph J. ; et al.	2011-01-06
Compositions and Methods for Producing Adaptive Regulatory T Cells App 20100183575 - Noelle; Randolph J.	2010-07-22
Methods for reducing T cell responsiveness to an autoantigen with anti-gp39 antibodies and antigen presenting cells Grant 7,722,874 - Noelle , et al. May 25, 2	2010-05-25
Immunostimulatory Combinations App 20090123460 - NOELLE; Randolph J. ; et al.	2009-05-14
Methods of inducing T-cell non-responsiveness with anti-gp39 24-31 antibodies Grant 7,501,124 - Noelle , et al. March 10, 2	2009-03-10
Methods of inhibiting IgE responses to thymus-dependent antigens with the anti-gp39 antibody MR1 Grant 7,476,385 - Noelle , et al. January 13, 2	2009-01-13
Regulatory T Cell Mediator Proteins and Uses Thereof App 20080287358 - Noelle; Randolph J. ; et al.	2008-11-20
Anti-CD40CR MR1 antibody Grant 7,445,781 - Noelle November 4, 2	2008-11-04
Method for Modulating Inflammatory Responses App 20080220006 - Noelle; Randolph J. ; et al.	2008-09-11
Immunostimulatory combinations Grant 7,387,271 - Noelle , et al. June 17, 2	2008-06-17
Methods for inducing antigen-specific T cell tolerance App 20060222649 - Noelle; Randolph J. ; et al.	2006-10-05
Monoclonal antibody MR1 and uses thereof App 20060008460 - Noelle; Randolph J.	2006-01-12
Method for prolonged suppression of humoral immune response to a thymus-dependent antigen App 20050163780 - Noelle, Randolph J. ; et al.	2005-07-28
Methods for inducing T cell tolerance to a tissue or organ graft App 20050152897 - Noelle, Randolph J. ; et al.	2005-07-14
Treatment of T cell mediated autoimmune disorders App 20040197327 - Noelle, Randolph J.	2004-10-07
Immunostimulatory combinations App 20040141950 - Noelle, Randolph J. ; et al.	2004-07-22
Methods For Inducing Antigen-specific T Cell Tolerance App 20020187135 - NOELLE, RANDOLPH J. ; et al.	2002-12-12
Use of anti-gp-39 antibodies for treatment and/or reversal of lupus and lupus associated kidney disease App 20020058037 - Noelle, Randolph J. ; et al.	2002-05-16
Ex vivo treatment of allogeneic and xenogeneic donor T-cells containing compositions (bone marrow) using gp39 antagonists and use thereof App 20020048579 - Noelle, Randolph J. ; et al.	2002-04-25
Methods for inducing T cell unresponsiveness to donor tissue or organ in a recipient with gp39 antagonists Grant 6,375,950 - Noelle , et al. April 23, 2	2002-04-23
Ex vivo treatment of allogeneic and xenogeneic donor T-cells containing compositions (bone marrow) using gp39 antagonists and use thereof App 20020022020 - Noelle, Randolph J. ; et al.	2002-02-21
Treatment of T cell mediated autoimmune disorders App 20020009450 - Noelle, Randolph J. ; et al.	2002-01-24
Method to treat multiple sclerosis with GP39-specific antibodies Grant 6,328,964 - Noelle , et al. December 11, 2	2001-12-11
Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells Grant 6,312,692 - Noelle , et al. November 6, 2	2001-11-06
Method for prolonged suppression of humoral immune response to a thymus-dependent antigen therapeutic agent Grant 5,942,229 - Noelle , et al. August 24, 1	1999-08-24
Methods of inducing T cell unresponsiveness to donor tissue or organ in a recipient with GP39 antagonists Grant 5,902,585 - Noelle , et al. May 11, 1	1999-05-11
Methods of inducing T cell non-responsiveness to transplanted tissues and of treating graft-versus-host-disease with anti-gp39 antibodies Grant 5,876,718 - Noelle , et al. March 2, 1	1999-03-02
Methods of inducing T cell unresponsiveness to bone marrow with gp39 antagonists Grant 5,869,049 - Noelle , et al. February 9, 1	1999-02-09
Treatment of T cell mediated autoimmune disorders Grant 5,833,987 - Noelle , et al. November 10, 1	1998-11-10
Anti-GP39 antibodies Grant 5,747,037 - Noelle , et al. May 5, 1	1998-05-05
Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40 Grant 5,683,693 - Noelle , et al. November 4, 1	1997-11-04

Company Registrations

NCAGE Code	49J67	NOELLE RANDOLPH J
CAGE Code	49J67	NOELLE, RANDOLPH J
DUNS	616383910	NOELLE, RANDOLPH J

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.